Dr. Pelletier is a Clinical Professor of Medicine, Dept. of Medicine; Dept. of Family and Community Medicine; and Dept. of Psychiatry at the University of California School of Medicine (UCSF) in San Francisco. At UCSF Med, he is the Director of the Corporate Health Improvement Program (CHIP) a collaborative research program between CHIP and fifteen Fortune 500 corporations including Ford, Oracle, Prudential, Dow, Lockheed Martin, NASA, Pepsico, IBM, Cummins, Steelcase, and the Mayo Clinic. He is also Chairman of the AHA and a Vice President with American Specialty Health (ASH).Dr. Pelletier is a medical and business consultant to the USDHHS, the WHO, the NBGH, the Federation of State Medical Boards, and major corporations including Cisco, IBM, American Airlines, Prudential, Dow, Disney, Ford, Mercer, Merck, Pepsico, Ford, Pfizer, Walgreens, NASA, Microsoft ENCARTA, Blue Cross/Blue Shield, United Healthcare, Health Net, the Pasteur Institute of Lille, France, the Alpha Group of Mexico, and the Singapore Ministry of Health.He has or currently serves serves on the boards of Rancho la Puerta (Mexico), Fries Foundation, American Institute of Stress (AIS), American Journal of Health Promotion (AJHP), is a Founding Board Member of the American Board of Integrative Medicine (ABOIM), and as a peer reviewer for the Journal of the American Medical Association (JAMA), the Journal of Occupational and Environmental Medicine (JOEM), Annals of Internal Medicine, Health Affairs, and webMD.
